PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
We used Diffuse Reflectance spectroscopy (DRS) to investigate functional changes within the tumor microenvironment when treated with different immunotherapy drugs. We injected the CT26 cell line into the flank of 35 mice that were assigned to 4 different groups: anti-PD-1, anti-CTLA-4, combination treatment, and IgG. The 4 groups were injected intraperitoneally on days 1, 4 and 7 (Day 1 – tumor at 80-120 mm3). DRS spectra were acquired simultaneously for 9 consecutive days and a lookup table (LUT)-based inverse model was implemented to decompose the spectral data. We found statistically significant differences in functional changes among the different immunotherapy groups.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Joel Rodriguez Troncoso, Paola Monterroso Diaz, David E. Lee, Narasimhan Rajaram, "Optical spectroscopy to monitor tumor response to immunotherapy," Proc. SPIE 11622, Multiscale Imaging and Spectroscopy II, 1162209 (5 March 2021); https://doi.org/10.1117/12.2577873